Skip Ribbon Commands
Skip to main content
Sign In
Navigate Up

25071 Diphtheria Toxoid IgG (DIPGS)

Diphtheria Toxoid IgG (DIPGS)
Test Code: DIPGSO
Synonyms/Keywords
Anti-diphtheria toxoid, Corynebacterium diphtheria, Diphtheria Immune Response, Diphtheria toxoid antibodies
Useful For
Determining the vaccination status of an individual to diptheria toxoid.
Specimen Requirements
Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)		 Pediatric Minimum Volume
(no repeat)
Serum​ Serum Separator Tube (SST) Red Top Tube (RTT) ​0.5 mL ​0.4 mL ​
Specimen Stability Information
Specimen Type Temperature Time
​Serum ​Refrigerated (preferred) 30 days
​ ​Frozen ​30 days
Rejection Criteria
​​Gross Hemolysis
​Gross Lipemia
​Gross Icterus
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
​Mayo Medical Laboratories Monday through Friday​ 1 day
Enzyme Immunoassay (EIA)​
Reference Lab
Mayo Clinic Laboratories
Test Information

This test should be regarded as 'Research Use Only'. This test has not been cleared or approved by the U.S. Food and Drug Administration. It may not be covered by insurance and providers need to inform all patients of this prior to ordering. 

For Medicare patients, an Advanced Beneficiary notice (ABN) is required; for Medicaid patients, a Noncovered Services Waiver is required, and for commercial payers, prior authorization should be obtained.   ​

In the United States, diphtheria toxoid is administered to children as part of the combined diphtheria-pertussis-tetanus vaccine. Anti-diphtheria toxoid antibodies form in response to vaccination using diphtheria toxoid protein. 

This immunoassay, which uses the same protein (toxoid) that is used in the vaccine, provides a measurement of specific IgG antibodies produced in response to vaccination. ​
Reference Range Information
Vaccinated: POSITIVE (>=0.01 IU/mL)
Unvaccinated: NEGATIVE (<0.01 IU/mL)
Outreach CPTs
CPT Modifier
(if needed)		 Quantity Description Comments
​86317 ​ ​ ​ ​
Classification

This test should be regarded as 'Research Use Only'. This test has not been cleared or approved by the U.S. Food and Drug Administration. It may not be covered by insurance and providers need to inform all patients of this prior to ordering. 

For Medicare patients, an Advanced Beneficiary notice (ABN) is required; for Medicaid patients, a Noncovered Services Waiver is required, and for commercial payers, prior authorization should be obtained.   ​

Synonyms/Keywords
Anti-diphtheria toxoid, Corynebacterium diphtheria, Diphtheria Immune Response, Diphtheria toxoid antibodies
Ordering Applications
Ordering Application Description
​Centricity ​Diphtheria Toxoid IgG (83262)
​Cerner ​Diphtheria Toxoid IgG (83262)
​COM ​DiphtheriaToxoid, IgG
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)		 Pediatric Minimum Volume
(no repeat)
Serum​ Serum Separator Tube (SST) Red Top Tube (RTT) ​0.5 mL ​0.4 mL ​
Specimen Stability Information
Specimen Type Temperature Time
​Serum ​Refrigerated (preferred) 30 days
​ ​Frozen ​30 days
Rejection Criteria
​​Gross Hemolysis
​Gross Lipemia
​Gross Icterus
Useful For
Determining the vaccination status of an individual to diptheria toxoid.
Reference Range Information
Vaccinated: POSITIVE (>=0.01 IU/mL)
Unvaccinated: NEGATIVE (<0.01 IU/mL)
For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
​Mayo Medical Laboratories Monday through Friday​ 1 day
Enzyme Immunoassay (EIA)​
Reference Lab
Mayo Clinic Laboratories
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)		 Quantity Description Comments
​86317 ​ ​ ​ ​
Classification

This test should be regarded as 'Research Use Only'. This test has not been cleared or approved by the U.S. Food and Drug Administration. It may not be covered by insurance and providers need to inform all patients of this prior to ordering. 

For Medicare patients, an Advanced Beneficiary notice (ABN) is required; for Medicaid patients, a Noncovered Services Waiver is required, and for commercial payers, prior authorization should be obtained.   ​

For most current information refer to the Marshfield Laboratory online reference manual.